We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
HRAS
SECTIONS
  • TISSUE
  • BRAIN
  • SINGLE CELL TYPE
  • TISSUE CELL TYPE
  • PATHOLOGY
  • DISEASE
  • IMMUNE CELL
  • BLOOD PROTEIN
  • SUBCELLULAR
  • CELL LINE
  • STRUCTURE
  • METABOLIC
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
  • SARS-COV-2
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Patient ID
Tissue
Category
Cluster
Reliability
Brain region
Category
Brain region
Category
Brain region
Category
Reliability
Cell type
Category
Cluster
Tissue
Cell type
Enrichment
Cancer
Prognosis
Cancer
Category
Cell type
Category
Cell lineage
Category
Cluster
Annotation
Disease
Location
Searches
Location
Cell line
Type
Phase
Reliability
Cancer type
Category
Cluster
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Protein structure
In atlas
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • TISSUE CELL

  • PATHOLOGY

  • DISEASE

  • IMMUNE

  • BLOOD

  • SUBCELL

  • CELL LINE

  • STRUCTURE

  • METABOLIC

  • HRAS
PROTEIN STRUCTURE
ANTIBODIES
AND
VALIDATION
Protein structures
GENERAL INFORMATIONi

General description of the gene and the encoded protein(s) using information from HGNC and Ensembl, as well as predictions made by the Human Protein Atlas project.

Gene namei

Official gene symbol, which is typically a short form of the gene name, according to HGNC.

HRAS
Synonyms HRAS1
Gene descriptioni

Full gene name according to HGNC.

HRas proto-oncogene, GTPase
Protein classi

Assigned HPA protein class(es) for the encoded protein(s).

Read more
Cancer-related genes
Disease related genes
Enzymes
Human disease related genes
Plasma proteins
Potential drug targets
RAS pathway related proteins
Predicted locationi

All transcripts of all genes have been analyzed regarding the location(s) of corresponding protein based on prediction methods for signal peptides and transmembrane regions.

  • Genes with at least one transcript predicted to encode a secreted protein, according to prediction methods or to UniProt location data, have been further annotated and classified with the aim to determine if the corresponding protein(s) are secreted or actually retained in intracellular locations or membrane-attached.

  • Remaining genes, with no transcript predicted to encode a secreted protein, will be assigned the prediction-based location(s).

The annotated location overrules the predicted location, so that a gene encoding a predicted secreted protein that has been annotated as intracellular will have intracellular as the final location.

Read more
Intracellular
Protein evidence Evidence at protein level (all genes)
GENE INFORMATIONi

Gene information from Ensembl and Entrez, as well as links to available gene identifiers are displayed here. Information was retrieved from Ensembl if not indicated otherwise.

Chromosome 11
Cytoband p15.5
Chromosome location (bp) 532242 - 537287
Number of transcriptsi

Number of protein-coding transcripts from the gene as defined by Ensembl.

5
Ensembl ENSG00000174775 (version 103.38)
Entrez gene 3265
HGNC HGNC:5173
UniProt P01112 (UniProt - Evidence at protein level)
neXtProt NX_P01112
Antibodypedia HRAS antibodies


PROTEIN STRUCTUREi

The Structure section provides predicted structures from the Alphafold protein structure database and available experimental structures from Protein Data Bank (PDB).

In the Structure drop-down menu all experimental structures from PDB are available for selection and display. The structures are displayed using the NGL Viewer and can be zoomed-in and rotated either manually or by checking the Autorotate box. The Color scheme can be selected to show the residue index, chain name or confidence score (as B-factors and pLDDT score for experimental and predicted structures, respectively). The positions for available antigen sequences in the structure are shown if Antigens is turned to ON, and the Variants slider can be used to show the positions of clinical and population variants.https://github.com/nglviewer/ngl

Read more

Predicted


Description: Structure prediction from Alphafold project. Structure version 2

# Chains: 1      # Clinical variants: 29      # Population variants: 98

Experimental

Description: STRUKTUR UND GUANOSINTRIPHOSPHAT-HYDROLYSEMECHANISMUS DES C-TERMINAL VERKUERZTEN MENSCHLICHEN KREBSPROTEINS P21-H-RAS (X-ray)

# Chains: 1      # Clinical variants: 0      # Population variants: 0

Antigens:

Off
On

Variants:

Off
Clinical
Population

Color scheme:

Confidence
Residue index
Chain name

Autorotate:

Off
On



PROTEIN BROWSERi

The protein browser displays the antigen location on the target protein(s) and the features of the target protein. The tabs at the top of the protein view section can be used to switch between the different splice variants to which an antigen has been mapped.

At the top of the view, the position of the antigen (identified by the corresponding HPA identifier) is shown as a green bar. A yellow triangle on the bar indicates a <100% sequence identity to the protein target.

Below the antigens, the maximum percent sequence identity of the protein to all other proteins from other human genes is displayed, using a sliding window of 10 aa residues (HsID 10) or 50 aa residues (HsID 50). The region with the lowest possible identity is always selected for antigen design, with a maximum identity of 60% allowed for designing a single-target antigen (read more).

The curve in blue displays the predicted antigenicity i.e. the tendency for different regions of the protein to generate an immune response, with peak regions being predicted to be more antigenic.The curve shows average values based on a sliding window approach using an in-house propensity scale. (read more).

If a signal peptide is predicted by a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius (turquoise) and/or transmembrane regions (orange) are predicted by MDM, these are displayed.

Low complexity regions are shown in yellow and InterPro regions in green. Common (purple) and unique (grey) regions between different splice variants of the gene are also displayed (read more), and at the bottom of the protein view is the protein scale.
HRAS-201
HRAS-202
HRAS-203
HRAS-204
HRAS-205


PROTEIN INFORMATIONi

The protein information section displays alternative protein-coding transcripts (splice variants) encoded by this gene according to the Ensembl database.

The ENSP identifier links to the Ensembl website protein summary, while the ENST identifier links to the Ensembl website transcript summary for the selected splice variant. The data in the UniProt column can be expanded to show links to all matching UniProt identifiers for this protein.

The protein classes assigned to this protein are shown if expanding the data in the protein class column. Parent protein classes are in bold font and subclasses are listed under the parent class.

The Gene Ontology terms assigned to this protein are listed if expanding the Gene ontology column. The length of the protein (amino acid residues according to Ensembl), molecular mass (kDalton), predicted signal peptide (according to a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius) and the number of predicted transmembrane region(s) (according to MDM) are also reported.
Splice variant UniProt Protein class Gene ontology Length & mass Signal peptide
(predicted)
Transmembrane regions
(predicted)
HRAS-201
ENSP00000309845
ENST00000311189
P01112 [Direct mapping]
GTPase HRas GTPase HRas, N-terminally processed
X5D945 [Target identity:100%; Query identity:100%]
Harvey rat sarcoma viral oncoprotein isoform A; V-Ha-ras Harvey rat sarcoma viral oncogene homolog, isoform CRA_a
Show all
Enzymes
   ENZYME proteins
   Hydrolases
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
RAS pathway related proteins
Cancer-related genes
   Candidate cancer biomarkers
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
Disease related genes
Potential drug targets
Human disease related genes
   Cancers
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of endocrine organs
   Congenital malformations
   Other congenital malformations
   Musculoskeletal diseases
   Skeletal diseases
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000139 [Golgi membrane]
GO:0000165 [MAPK cascade]
GO:0000166 [nucleotide binding]
GO:0001934 [positive regulation of protein phosphorylation]
GO:0002223 [stimulatory C-type lectin receptor signaling pathway]
GO:0003924 [GTPase activity]
GO:0005515 [protein binding]
GO:0005525 [GTP binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005737 [cytoplasm]
GO:0005794 [Golgi apparatus]
GO:0005829 [cytosol]
GO:0005886 [plasma membrane]
GO:0006935 [chemotaxis]
GO:0007050 [cell cycle arrest]
GO:0007165 [signal transduction]
GO:0007166 [cell surface receptor signaling pathway]
GO:0007265 [Ras protein signal transduction]
GO:0008022 [protein C-terminus binding]
GO:0008284 [positive regulation of cell population proliferation]
GO:0008285 [negative regulation of cell population proliferation]
GO:0009887 [animal organ morphogenesis]
GO:0010629 [negative regulation of gene expression]
GO:0010863 [positive regulation of phospholipase C activity]
GO:0016020 [membrane]
GO:0016787 [hydrolase activity]
GO:0019003 [GDP binding]
GO:0030335 [positive regulation of cell migration]
GO:0034260 [negative regulation of GTPase activity]
GO:0043406 [positive regulation of MAP kinase activity]
GO:0043410 [positive regulation of MAPK cascade]
GO:0043547 [positive regulation of GTPase activity]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046330 [positive regulation of JNK cascade]
GO:0048013 [ephrin receptor signaling pathway]
GO:0048471 [perinuclear region of cytoplasm]
GO:0050679 [positive regulation of epithelial cell proliferation]
GO:0070374 [positive regulation of ERK1 and ERK2 cascade]
GO:0071480 [cellular response to gamma radiation]
GO:0090303 [positive regulation of wound healing]
GO:0090314 [positive regulation of protein targeting to membrane]
GO:0090398 [cellular senescence]
GO:0098696 [regulation of neurotransmitter receptor localization to postsynaptic specialization membrane]
GO:0098978 [glutamatergic synapse]
GO:1900029 [positive regulation of ruffle assembly]
GO:2000251 [positive regulation of actin cytoskeleton reorganization]
GO:2000630 [positive regulation of miRNA metabolic process]
Show all
189 aa
21.3 kDa
No 0
HRAS-202
ENSP00000380722
ENST00000397594
P01112 [Direct mapping]
GTPase HRas GTPase HRas, N-terminally processed
Show all
Enzymes
   ENZYME proteins
   Hydrolases
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
RAS pathway related proteins
Cancer-related genes
   Candidate cancer biomarkers
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
Disease related genes
Potential drug targets
Human disease related genes
   Cancers
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of endocrine organs
   Congenital malformations
   Other congenital malformations
   Musculoskeletal diseases
   Skeletal diseases
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000139 [Golgi membrane]
GO:0000165 [MAPK cascade]
GO:0000166 [nucleotide binding]
GO:0001934 [positive regulation of protein phosphorylation]
GO:0002223 [stimulatory C-type lectin receptor signaling pathway]
GO:0003924 [GTPase activity]
GO:0005515 [protein binding]
GO:0005525 [GTP binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005737 [cytoplasm]
GO:0005794 [Golgi apparatus]
GO:0005829 [cytosol]
GO:0005886 [plasma membrane]
GO:0006935 [chemotaxis]
GO:0007050 [cell cycle arrest]
GO:0007165 [signal transduction]
GO:0007166 [cell surface receptor signaling pathway]
GO:0007265 [Ras protein signal transduction]
GO:0008022 [protein C-terminus binding]
GO:0008284 [positive regulation of cell population proliferation]
GO:0008285 [negative regulation of cell population proliferation]
GO:0009887 [animal organ morphogenesis]
GO:0010629 [negative regulation of gene expression]
GO:0010863 [positive regulation of phospholipase C activity]
GO:0016020 [membrane]
GO:0016787 [hydrolase activity]
GO:0019003 [GDP binding]
GO:0030335 [positive regulation of cell migration]
GO:0034260 [negative regulation of GTPase activity]
GO:0043406 [positive regulation of MAP kinase activity]
GO:0043410 [positive regulation of MAPK cascade]
GO:0043547 [positive regulation of GTPase activity]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046330 [positive regulation of JNK cascade]
GO:0048013 [ephrin receptor signaling pathway]
GO:0048471 [perinuclear region of cytoplasm]
GO:0050679 [positive regulation of epithelial cell proliferation]
GO:0070374 [positive regulation of ERK1 and ERK2 cascade]
GO:0071480 [cellular response to gamma radiation]
GO:0090303 [positive regulation of wound healing]
GO:0090314 [positive regulation of protein targeting to membrane]
GO:0090398 [cellular senescence]
GO:0098696 [regulation of neurotransmitter receptor localization to postsynaptic specialization membrane]
GO:0098978 [glutamatergic synapse]
GO:1900029 [positive regulation of ruffle assembly]
GO:2000251 [positive regulation of actin cytoskeleton reorganization]
GO:2000630 [positive regulation of miRNA metabolic process]
Show all
170 aa
18.9 kDa
No 0
HRAS-203
ENSP00000380723
ENST00000397596
P01112 [Direct mapping]
GTPase HRas GTPase HRas, N-terminally processed
X5D945 [Target identity:100%; Query identity:100%]
Harvey rat sarcoma viral oncoprotein isoform A; V-Ha-ras Harvey rat sarcoma viral oncogene homolog, isoform CRA_a
Show all
Enzymes
   ENZYME proteins
   Hydrolases
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
RAS pathway related proteins
Cancer-related genes
   Candidate cancer biomarkers
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
Disease related genes
Potential drug targets
Human disease related genes
   Cancers
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of endocrine organs
   Congenital malformations
   Other congenital malformations
   Musculoskeletal diseases
   Skeletal diseases
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000139 [Golgi membrane]
GO:0000165 [MAPK cascade]
GO:0000166 [nucleotide binding]
GO:0001934 [positive regulation of protein phosphorylation]
GO:0002223 [stimulatory C-type lectin receptor signaling pathway]
GO:0003924 [GTPase activity]
GO:0005515 [protein binding]
GO:0005525 [GTP binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005737 [cytoplasm]
GO:0005794 [Golgi apparatus]
GO:0005829 [cytosol]
GO:0005886 [plasma membrane]
GO:0006935 [chemotaxis]
GO:0007050 [cell cycle arrest]
GO:0007165 [signal transduction]
GO:0007166 [cell surface receptor signaling pathway]
GO:0007265 [Ras protein signal transduction]
GO:0008022 [protein C-terminus binding]
GO:0008284 [positive regulation of cell population proliferation]
GO:0008285 [negative regulation of cell population proliferation]
GO:0009887 [animal organ morphogenesis]
GO:0010629 [negative regulation of gene expression]
GO:0010863 [positive regulation of phospholipase C activity]
GO:0016020 [membrane]
GO:0016787 [hydrolase activity]
GO:0019003 [GDP binding]
GO:0030335 [positive regulation of cell migration]
GO:0034260 [negative regulation of GTPase activity]
GO:0043406 [positive regulation of MAP kinase activity]
GO:0043410 [positive regulation of MAPK cascade]
GO:0043547 [positive regulation of GTPase activity]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046330 [positive regulation of JNK cascade]
GO:0048013 [ephrin receptor signaling pathway]
GO:0048471 [perinuclear region of cytoplasm]
GO:0050679 [positive regulation of epithelial cell proliferation]
GO:0070374 [positive regulation of ERK1 and ERK2 cascade]
GO:0071480 [cellular response to gamma radiation]
GO:0090303 [positive regulation of wound healing]
GO:0090314 [positive regulation of protein targeting to membrane]
GO:0090398 [cellular senescence]
GO:0098696 [regulation of neurotransmitter receptor localization to postsynaptic specialization membrane]
GO:0098978 [glutamatergic synapse]
GO:1900029 [positive regulation of ruffle assembly]
GO:2000251 [positive regulation of actin cytoskeleton reorganization]
GO:2000630 [positive regulation of miRNA metabolic process]
Show all
189 aa
21.3 kDa
No 0
HRAS-204
ENSP00000388246
ENST00000417302
P01112 [Direct mapping]
GTPase HRas GTPase HRas, N-terminally processed
Show all
Enzymes
   ENZYME proteins
   Hydrolases
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
RAS pathway related proteins
Cancer-related genes
   Candidate cancer biomarkers
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
Disease related genes
Potential drug targets
Human disease related genes
   Cancers
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of endocrine organs
   Congenital malformations
   Other congenital malformations
   Musculoskeletal diseases
   Skeletal diseases
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000139 [Golgi membrane]
GO:0000165 [MAPK cascade]
GO:0000166 [nucleotide binding]
GO:0001934 [positive regulation of protein phosphorylation]
GO:0002223 [stimulatory C-type lectin receptor signaling pathway]
GO:0003924 [GTPase activity]
GO:0005515 [protein binding]
GO:0005525 [GTP binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005737 [cytoplasm]
GO:0005794 [Golgi apparatus]
GO:0005829 [cytosol]
GO:0005886 [plasma membrane]
GO:0006935 [chemotaxis]
GO:0007050 [cell cycle arrest]
GO:0007165 [signal transduction]
GO:0007166 [cell surface receptor signaling pathway]
GO:0007265 [Ras protein signal transduction]
GO:0008022 [protein C-terminus binding]
GO:0008284 [positive regulation of cell population proliferation]
GO:0008285 [negative regulation of cell population proliferation]
GO:0009887 [animal organ morphogenesis]
GO:0010629 [negative regulation of gene expression]
GO:0010863 [positive regulation of phospholipase C activity]
GO:0016020 [membrane]
GO:0016787 [hydrolase activity]
GO:0019003 [GDP binding]
GO:0030335 [positive regulation of cell migration]
GO:0034260 [negative regulation of GTPase activity]
GO:0043406 [positive regulation of MAP kinase activity]
GO:0043410 [positive regulation of MAPK cascade]
GO:0043547 [positive regulation of GTPase activity]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046330 [positive regulation of JNK cascade]
GO:0048013 [ephrin receptor signaling pathway]
GO:0048471 [perinuclear region of cytoplasm]
GO:0050679 [positive regulation of epithelial cell proliferation]
GO:0070374 [positive regulation of ERK1 and ERK2 cascade]
GO:0071480 [cellular response to gamma radiation]
GO:0090303 [positive regulation of wound healing]
GO:0090314 [positive regulation of protein targeting to membrane]
GO:0090398 [cellular senescence]
GO:0098696 [regulation of neurotransmitter receptor localization to postsynaptic specialization membrane]
GO:0098978 [glutamatergic synapse]
GO:1900029 [positive regulation of ruffle assembly]
GO:2000251 [positive regulation of actin cytoskeleton reorganization]
GO:2000630 [positive regulation of miRNA metabolic process]
Show all
170 aa
18.9 kDa
No 0
HRAS-205
ENSP00000407586
ENST00000451590
P01112 [Direct mapping]
GTPase HRas GTPase HRas, N-terminally processed
X5D945 [Target identity:100%; Query identity:100%]
Harvey rat sarcoma viral oncoprotein isoform A; V-Ha-ras Harvey rat sarcoma viral oncogene homolog, isoform CRA_a
Show all
Enzymes
   ENZYME proteins
   Hydrolases
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
RAS pathway related proteins
Cancer-related genes
   Candidate cancer biomarkers
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
Disease related genes
Potential drug targets
Human disease related genes
   Cancers
   Skin cancers
   Cancers of soft tissues and bone
   Cancers of the breast and female genital organs
   Cancers of male genital organs
   Cancers of the urinary system
   Cancers of endocrine organs
   Congenital malformations
   Other congenital malformations
   Musculoskeletal diseases
   Skeletal diseases
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000139 [Golgi membrane]
GO:0000165 [MAPK cascade]
GO:0000166 [nucleotide binding]
GO:0001889 [liver development]
GO:0001934 [positive regulation of protein phosphorylation]
GO:0002223 [stimulatory C-type lectin receptor signaling pathway]
GO:0003924 [GTPase activity]
GO:0005515 [protein binding]
GO:0005525 [GTP binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005737 [cytoplasm]
GO:0005794 [Golgi apparatus]
GO:0005829 [cytosol]
GO:0005886 [plasma membrane]
GO:0006897 [endocytosis]
GO:0006915 [apoptotic process]
GO:0006935 [chemotaxis]
GO:0007050 [cell cycle arrest]
GO:0007165 [signal transduction]
GO:0007166 [cell surface receptor signaling pathway]
GO:0007264 [small GTPase mediated signal transduction]
GO:0007265 [Ras protein signal transduction]
GO:0007569 [cell aging]
GO:0008022 [protein C-terminus binding]
GO:0008284 [positive regulation of cell population proliferation]
GO:0008285 [negative regulation of cell population proliferation]
GO:0009887 [animal organ morphogenesis]
GO:0010628 [positive regulation of gene expression]
GO:0010629 [negative regulation of gene expression]
GO:0010863 [positive regulation of phospholipase C activity]
GO:0016020 [membrane]
GO:0016787 [hydrolase activity]
GO:0019003 [GDP binding]
GO:0030335 [positive regulation of cell migration]
GO:0032729 [positive regulation of interferon-gamma production]
GO:0034260 [negative regulation of GTPase activity]
GO:0035900 [response to isolation stress]
GO:0042088 [T-helper 1 type immune response]
GO:0042832 [defense response to protozoan]
GO:0043231 [intracellular membrane-bounded organelle]
GO:0043406 [positive regulation of MAP kinase activity]
GO:0043410 [positive regulation of MAPK cascade]
GO:0043524 [negative regulation of neuron apoptotic process]
GO:0043547 [positive regulation of GTPase activity]
GO:0044877 [protein-containing complex binding]
GO:0045740 [positive regulation of DNA replication]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046330 [positive regulation of JNK cascade]
GO:0046579 [positive regulation of Ras protein signal transduction]
GO:0048013 [ephrin receptor signaling pathway]
GO:0048169 [regulation of long-term neuronal synaptic plasticity]
GO:0048471 [perinuclear region of cytoplasm]
GO:0050679 [positive regulation of epithelial cell proliferation]
GO:0050852 [T cell receptor signaling pathway]
GO:0070374 [positive regulation of ERK1 and ERK2 cascade]
GO:0071480 [cellular response to gamma radiation]
GO:0090303 [positive regulation of wound healing]
GO:0090314 [positive regulation of protein targeting to membrane]
GO:0090398 [cellular senescence]
GO:0097193 [intrinsic apoptotic signaling pathway]
GO:0098696 [regulation of neurotransmitter receptor localization to postsynaptic specialization membrane]
GO:0098978 [glutamatergic synapse]
GO:1900029 [positive regulation of ruffle assembly]
GO:2000251 [positive regulation of actin cytoskeleton reorganization]
GO:2000630 [positive regulation of miRNA metabolic process]
Show all
189 aa
21.3 kDa
No 0

Contact

  • NEWS ARTICLES
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.